Dietary butyrate treatment enhances healthy metabolites by longitudinal untargeted metabolomic analysis in amyotrophic lateral sclerosis mice
D. Ogbu, Y.-g. Zhang, K. Claud, Y. Xia, J. Sun
This study uses longitudinal metabolomic analysis to show that butyrate treatment in ALS mice alters metabolites, inflammation, and microglia, suggesting potential therapeutic applications.
bioRxiv · Jan 15, 2022 · PreprintPhysiology